Process for a direct one-pot transformation of lutein to β-cryptoxanthin via its acetate ester

US9725411B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-9725411-B2
Application numberUS-201414891499-A
CountryUS
Kind codeB2
Filing dateMay 16, 2014
Priority dateMay 16, 2013
Publication dateAug 8, 2017
Grant dateAug 8, 2017

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

The present invention relates to a process for converting commercially available lutein and/or lutein esters from extracts of marigold flower petals to (3R)-β-cryptoxanthin (major) and (3R,6′R)-α-cryptoxanthin (minor) in ratios ranging from 95:5 to 98:2 in a one-pot reaction at room temperature. Because the entire process can be carried out by employing safe and environmentally friendly food-grade reagents, the resulting mixture of these carotenoids is suitable for human consumption as a dietary supplement.

First claim

Opening claim text (preview).

What is claimed is: 1. A process for the preparation of (3R)-β-cryptoxanthin acetate comprising reacting (3R,3′R,6′R)-lutein with concentrated mineral acid or a strong organic acid, a heterogeneous hydrogenation catalyst, an acylating ester, and hydrogen in one reaction to give (3R)-β-cryptoxanthin acetate. 2. The process of claim 1 , wherein the (3R,3′R,6′R)-lutein is purified by pretreatment with a dilute solution of a mineral acid in an alcohol at a temperature between about 50° C. to about 60° C. to remove anthocyanins and degradation products of chlorophylls. 3. The process of claim 1 , further comprising a solvent selected from the group consisting of acetone, tetrahydrofuran, a hydrocarbon solvent, and combinations thereof. 4. The process of claim 1 , wherein the acylating ester is selected from the group consisting of ethyl acetate, methyl acetate, isopropyl acetate, propyl acetate, and isopropenyl acetate. 5. The process of claim 3 , wherein the hydrocarbon solvent is selected from the group consisting of pentane, hexane, and heptane. 6. The process of claim 1 , wherein the concentrated mineral acid or strong organic acid is selected from the group consisting of about 50% sulfuric acid, hydrochloric acid, phosphoric acid, trifluoroacetic acid, and benzenesulfonic acid. 7. The process according to claim 1 , wherein the heterogeneous hydrogenation catalyst is selected from the group consisting of platinum (Pt) supported on alumina (5%), Pt supported on activated carbon (5%), Pt supported on activated carbon (10%), palladium (Pd) supported on activated carbon (5%), Pd supported on activated carbon (10%), Pd supported on alumina (5%), Pd supported on alumina (10%), Pd supported on calcium carbonate (5%), Pd 3% on polyethyleneimine/SiO 2 , rhodium (Rh) supported on alumina (5%), ruthenium supported on carbon, and ruthenium supported on alumina. 8. The process according to claim 1 , wherein the reacting is carried out at a temperature between about 23° C. to about 45° C. 9. The process of claim 1 , wherein the (3R,3′R,6′R)-lutein is present in a composition comprising 4-5% (3R,3′R)-zeaxanthin. 10. The process of claim 1 , wherein the (3R,3′R,6′R)-lutein may be present as lutein fatty acid esters in a composition comprising 4-5% (3R,3′R)-zeaxanthin fatty acid esters. 11. The process of claim 10 , wherein the lutein fatty acid esters are selected from the group consisting of lutein dimyristate, lutein dipalmitate, and combinations thereof. 12. The process of claim 10 , wherein the source of the lutein fatty acid esters is extracts of marigold flowers or marigold petal flowers. 13. The process of claim 10 , wherein the lutein fatty acid esters are purified by pretreatment with a dilute solution of a mineral acid in an alcohol at a temperature between about 50° C. and about 60° C. to remove the anthocyanins and degradation products of chlorophylls. 14. The process of claim 13 , wherein the mineral acid is selected from the group consisting of hydrochloric acid, sulfuric acid, and phosphoric acid.

Assignees

Inventors

Classifications

  • C07C403/24Primary

    having side-chains substituted by six-membered non-aromatic rings, e.g. beta-carotene · CPC title

  • the ring being unsaturated · CPC title

  • Chemistry & Metallurgy · mapped topic

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US9725411B2 cover?
The present invention relates to a process for converting commercially available lutein and/or lutein esters from extracts of marigold flower petals to (3R)-β-cryptoxanthin (major) and (3R,6′R)-α-cryptoxanthin (minor) in ratios ranging from 95:5 to 98:2 in a one-pot reaction at room temperature. Because the entire process can be carried out by employing safe and environmentally friendly food-gr…
Who is the assignee on this patent?
Univ Maryland
What technology area does this patent fall under?
Primary CPC classification C07C403/24. Mapped technology areas include Chemistry & Metallurgy.
When was this patent published?
Publication date Tue Aug 08 2017 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).